SCHEMBL6860429

SCHEMBL6860429

O=C(C=Cc1ccc(Cl)cc1)Nc1cccc([N+](=O)[O-])c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 8/20 0.76
KMT2A Q03164 8/20 0.63
RAB9A P51151 3/20 0.63
NPC1 O15118 2/20 0.63
TDP1 Q9NUW8 1/20 0.63
MEN1 O00255 7/20 0.61
MAPT P10636 5/20 0.61
ALDH1A1 P00352 4/20 0.61
MAPK1 P28482 3/20 0.61
NPSR1 Q6W5P4 2/20 0.61
CYP3A4 P08684 2/20 0.61
CYP2C19 P33261 2/20 0.61
HDAC6 Q9UBN7 1/20 0.61
TP53 P04637 1/20 0.61
CYP2C9 P11712 1/20 0.61
TSHR P16473 1/20 0.61
HSP90AA1 P07900 1/20 0.60
HPGD P15428 1/20 0.60
CACNA1B Q00975 1/20 0.60
APBA1 Q02410 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860426 1.00 TRPV1 (0.76) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL6754380 0.88 TRPV1 (0.73) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL6754378 0.88 TRPV1 (0.73) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL23547197 0.88 TRPV1 (0.73) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL15176833 0.86 TRPV1 (1.00) TRPV1KMT2ARAB9AMEN1MAPT
SCHEMBL13675641 0.84 KMT2A (0.67) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL21637256 0.80 MMP1 (0.81) TRPV1KMT2ARAB9ANPC1MEN1
SCHEMBL20526857 0.80 KMT2A (0.73) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL20526855 0.80 KMT2A (0.73) TRPV1KMT2ARAB9ANPC1TDP1
SCHEMBL30967986 0.80 KMT2A (0.73) TRPV1KMT2ARAB9ANPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040087798-A1 Novel amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 US disclosed
EP-1264820-A1 NOVEL AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087798-A1 Novel amide compounds H1-2, H1-0, H1-3 TRPV1 1618/4885KMT2A 130/4885RAB9A 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.